# Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab

> **NCT03115255** · NA · COMPLETED · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 17 (actual)

## Conditions studied

- Infant, Premature, Diseases

## Interventions

- **DRUG:** intravitreal ranibizumab

## Key facts

- **NCT ID:** NCT03115255
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-06-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2018-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03115255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03115255, "Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03115255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*